Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Hautarzt ; 71(11): 870-879, 2020 Nov.
Artículo en Alemán | MEDLINE | ID: mdl-32997218

RESUMEN

Vasculitis is a rare cause of skin ulceration. Depending on the size of the affected vessel, the patient's comorbidities and the pathophysiology present, different clinical morphologies can be seen, which can often give preliminary indications of the type of underlying vasculitis. There may be systemic or cutaneous manifestations; thus, a targeted diagnostic workup should be initiated at an early stage. Treatment should be interdisciplinary if there is systemic participation. Vasculopathies (e.g., livedoid vasculopathy), in which occlusion of the vascular lumen is the main pathophysiological feature, should be delimitated from vasculitis. If vasculitic or vasculopathic ulceration is present, stage-appropriate wound management is recommended.


Asunto(s)
Enfermedades Cutáneas Vasculares , Úlcera Cutánea , Vasculitis , Diagnóstico Diferencial , Humanos , Enfermedades Cutáneas Vasculares/diagnóstico , Enfermedades Cutáneas Vasculares/terapia , Úlcera Cutánea/diagnóstico , Úlcera Cutánea/terapia , Vasculitis/diagnóstico , Vasculitis/terapia
2.
Hautarzt ; 64(9): 685-94, 2013 Sep.
Artículo en Alemán | MEDLINE | ID: mdl-24022632

RESUMEN

BACKGROUND: Phlebologic diseases have become extremely common and have major socio-economic impact. However, the percentage of dermatologists working in phlebology appears to be decreasing according to the data of the German Society of Phlebology (DGP). METHODS: To investigate the reasons for this development, we--on behalf of the DGP--sent a questionnaire to 120 German Departments of Dermatology in autumn 2012. RESULTS: In 76 returned questionnaires, the number of physicians with additional fellowship training in phlebology averaged 1.5; the average number of those who fulfill the criteria for training fellows in phlebology was 0.9. In 71.1 % of the departments there was a phlebologist. A special phlebologic outpatient clinic existed in 73.7 % of the departments. Sonography with Doppler (89.5 %) and duplex (86.8 %) was used as the most frequent diagnostic tool. For therapy, compression (94.7 %), sclerotherapy (liquid 78.9 %, foam 63.2 %, catheter 18.4 %), endoluminal thermic procedures (radio wave 28.9 %, laser 17.1 %) and surgery (especially crossectomy and stripping 67.1 %, phlebectomy of tributaries 75 %) were used. The average number of treatments was very heterogenous in the different departments. CONCLUSIONS: Phlebology definitely plays an important role in dermatology. Most departments fulfill the formal criteria for the license to conduct advanced training in phlebology. A wide spectrum of phlebological diagnostic and therapeutic procedures is available.


Asunto(s)
Dermatología/estadística & datos numéricos , Departamentos de Hospitales/estadística & datos numéricos , Pautas de la Práctica en Medicina/estadística & datos numéricos , Enfermedades Cutáneas Vasculares/diagnóstico , Enfermedades Cutáneas Vasculares/terapia , Insuficiencia Venosa/diagnóstico , Insuficiencia Venosa/terapia , Alemania/epidemiología , Humanos , Competencia Profesional/estadística & datos numéricos , Enfermedades Cutáneas Vasculares/epidemiología , Encuestas y Cuestionarios , Insuficiencia Venosa/epidemiología
3.
Hautarzt ; 61(8): 705-16; quiz 717-8, 2010 Aug.
Artículo en Alemán | MEDLINE | ID: mdl-20644902

RESUMEN

The coagulation system protects the body from uncontrolled blood loss by means of highly regulated processes. In case of an injury the coagulation system instantly switches from controlled blood flow to acute coagulation and thrombus formation with the goal of stopping the blood loss. Minor changes in this well-maintained equilibrium of coagulation and blood flow tip the balance towards uncontrolled blood loss or even fatal thromboembolic events. Iatrogenic manipulation of this highly regulated system is possible with a variety of therapeutic agents. We review the basics of coagulation physiology and then discuss dermatologically relevant aspects of thrombosis prevention, as well as the use of anticoagulants to treat dermatologic diseases.


Asunto(s)
Anticoagulantes/uso terapéutico , Enfermedades de la Piel/tratamiento farmacológico , Tromboflebitis/tratamiento farmacológico , Coagulación Intravascular Diseminada/sangre , Coagulación Intravascular Diseminada/tratamiento farmacológico , Erisipela/sangre , Erisipela/tratamiento farmacológico , Hemangioma/tratamiento farmacológico , Hemangioma Capilar/sangre , Hemangioma Capilar/tratamiento farmacológico , Hemostasis/efectos de los fármacos , Hemostasis/fisiología , Humanos , Síndrome de Kasabach-Merritt , Enfermedades de la Piel/sangre , Neoplasias Cutáneas/tratamiento farmacológico , Síndrome de Sneddon/sangre , Síndrome de Sneddon/tratamiento farmacológico , Síndrome de Stevens-Johnson/sangre , Síndrome de Stevens-Johnson/tratamiento farmacológico , Tromboflebitis/sangre , Trombosis de la Vena/sangre , Trombosis de la Vena/prevención & control
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA